Suppr超能文献

[祖克坎德尔器官恶性交感神经节细胞瘤的治疗——一例报告]

[Therapy of a malignant sympathetic paraganglioma of the organ of Zuckerkandl--a case report].

作者信息

Schuppert F, Scheumann G F, Schöber C, Overbeck J, Schürmeyer T H, Schmoll H J, Dralle H, von zur Mühlen A

机构信息

Klinische Endokrinologie, Medizinische Hochschule Hannover.

出版信息

Klin Wochenschr. 1991 Dec 11;69(20):937-42. doi: 10.1007/BF01798547.

Abstract

We present a case report on a 35-year-old patient in whom a malignant sympathetic paraganglioma of the organ of Zuckerkandl was the cause of severe hypertension with excessive perspiration at night. Since curative surgery was not possible medical treatment was initiated. Interferon alfa 2b (Intron A, Essex Pharma) and the somatostatin-analogue SMS 201-995 (Sandostatin, Sandoz) had no effect on catecholamine production and progression of the tumor. Treatment with alpha-methyl-para-tyrosin (MPT, [Metyrosin], Demser, MSD) turned out to be an effective and well tolerable therapy in this patient with peritoneal carcinosis. Clinical and hormonal progression of the paraganglioma resumed only after two years of therapy, which constitutes the longest documented period of time of successful MPT treatment. The superior efficacy of MPT in our patient should encourage postoperative medical treatment with MPT in malignant pheochromocytoma or malignant paraganglioma, particularly when the tumor turns out to be resistent to alpha blocking drugs.

摘要

我们报告一例35岁患者,其位于主动脉体的恶性交感神经节旁瘤是导致严重高血压并伴有夜间多汗的原因。由于无法进行根治性手术,遂开始药物治疗。干扰素α-2b(Intron A,埃塞克斯制药公司)和生长抑素类似物SMS 201-995(善得定,山德士公司)对儿茶酚胺生成及肿瘤进展均无作用。α-甲基-对-酪氨酸(MPT,[美替拉酮],德美罗,默克雪兰诺公司)治疗对该患有腹膜癌的患者而言是一种有效且耐受性良好的疗法。仅在治疗两年后副神经节瘤的临床及激素水平进展才再次出现,这是有记录以来MPT成功治疗最长的时间段。MPT在我们这位患者身上的卓越疗效应促使在恶性嗜铬细胞瘤或恶性副神经节瘤术后使用MPT进行药物治疗,尤其是当肿瘤对α受体阻滞剂耐药时。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验